Medtech Financings for March 2013

Medtech financings for March 2013 came in at a total of $561 million, contributing to the trend of increased monthly fundings as well as average deal size.

Top financings for the month include:

  • $150 million for Mesoblast Ltd (stem cells for regenerative medicine)
  • $48 million for Nevro Corp. (spinal cord stimulation for treatment of pain)
  • $43 million for Avedro, Inc. (vision correction technologies)
  • $42 million for Alere, Inc. (device-based and other near-patient diagnostics)
  • $35 million for OvaScience, Inc. (egg precursor cells for treatment of infertility)
  • $33 million for Cardiovascular Systems, Inc., (atherectomy for treatment of peripheral artery disease)
  • $25 million for Topera Medical (3D mapping for arrhythmia)
  • $22.4 million for Saladax Biomedical (tests to aid in cancer drug dosage)
  • $19 million for SynCardia Systems, Inc. (total artificial heart)
  • $17.2 million for TranS1, Inc. (devices for treatment of conditions of the lumbar spine)

The complete list of medtech financings for March 2013 is shown at link.